PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM
The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
M. N. Povydysh [verfasserIn] V. G. Luzhanin [verfasserIn] D. Yu. Ivkin [verfasserIn] M. V. Belousov [verfasserIn] G. P. Yakovlev [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Russisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Разработка и регистрация лекарственных средств - LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020, (2019), 3, Seite 130-135 |
|---|---|
| Übergeordnetes Werk: |
year:2019 ; number:3 ; pages:130-135 |
| Links: |
|---|
| Katalog-ID: |
DOAJ029609100 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ029609100 | ||
| 003 | DE-627 | ||
| 005 | 20230410120327.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2019 xx |||||o 00| ||rus c | ||
| 035 | |a (DE-627)DOAJ029609100 | ||
| 035 | |a (DE-599)DOAJd62765a783af439a9d7dffcf6b4d59b9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 050 | 0 | |a HD9665-9675 | |
| 100 | 0 | |a M. N. Povydysh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials. | ||
| 650 | 4 | |a лекарственное растительное сырьё | |
| 650 | 4 | |a метаболический синдром | |
| 650 | 4 | |a индивидуальные вещества растительного происхожения | |
| 653 | 0 | |a Pharmaceutical industry | |
| 700 | 0 | |a V. G. Luzhanin |e verfasserin |4 aut | |
| 700 | 0 | |a D. Yu. Ivkin |e verfasserin |4 aut | |
| 700 | 0 | |a M. V. Belousov |e verfasserin |4 aut | |
| 700 | 0 | |a G. P. Yakovlev |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Разработка и регистрация лекарственных средств |d LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 |g (2019), 3, Seite 130-135 |w (DE-627)1760622966 |x 26585049 |7 nnns |
| 773 | 1 | 8 | |g year:2019 |g number:3 |g pages:130-135 |
| 856 | 4 | 0 | |u https://doaj.org/article/d62765a783af439a9d7dffcf6b4d59b9 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.pharmjournal.ru/jour/article/view/615 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2305-2066 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2658-5049 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |j 2019 |e 3 |h 130-135 | ||
| author_variant |
m n p mnp v g l vgl d y i dyi m v b mvb g p y gpy |
|---|---|
| matchkey_str |
article:26585049:2019----::rsetouightteaytiodroftncr |
| hierarchy_sort_str |
2019 |
| callnumber-subject-code |
HD |
| publishDate |
2019 |
| allfields |
(DE-627)DOAJ029609100 (DE-599)DOAJd62765a783af439a9d7dffcf6b4d59b9 DE-627 ger DE-627 rakwb rus HD9665-9675 M. N. Povydysh verfasserin aut PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials. лекарственное растительное сырьё метаболический синдром индивидуальные вещества растительного происхожения Pharmaceutical industry V. G. Luzhanin verfasserin aut D. Yu. Ivkin verfasserin aut M. V. Belousov verfasserin aut G. P. Yakovlev verfasserin aut In Разработка и регистрация лекарственных средств LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 (2019), 3, Seite 130-135 (DE-627)1760622966 26585049 nnns year:2019 number:3 pages:130-135 https://doaj.org/article/d62765a783af439a9d7dffcf6b4d59b9 kostenfrei https://www.pharmjournal.ru/jour/article/view/615 kostenfrei https://doaj.org/toc/2305-2066 Journal toc kostenfrei https://doaj.org/toc/2658-5049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2019 3 130-135 |
| spelling |
(DE-627)DOAJ029609100 (DE-599)DOAJd62765a783af439a9d7dffcf6b4d59b9 DE-627 ger DE-627 rakwb rus HD9665-9675 M. N. Povydysh verfasserin aut PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials. лекарственное растительное сырьё метаболический синдром индивидуальные вещества растительного происхожения Pharmaceutical industry V. G. Luzhanin verfasserin aut D. Yu. Ivkin verfasserin aut M. V. Belousov verfasserin aut G. P. Yakovlev verfasserin aut In Разработка и регистрация лекарственных средств LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 (2019), 3, Seite 130-135 (DE-627)1760622966 26585049 nnns year:2019 number:3 pages:130-135 https://doaj.org/article/d62765a783af439a9d7dffcf6b4d59b9 kostenfrei https://www.pharmjournal.ru/jour/article/view/615 kostenfrei https://doaj.org/toc/2305-2066 Journal toc kostenfrei https://doaj.org/toc/2658-5049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2019 3 130-135 |
| allfields_unstemmed |
(DE-627)DOAJ029609100 (DE-599)DOAJd62765a783af439a9d7dffcf6b4d59b9 DE-627 ger DE-627 rakwb rus HD9665-9675 M. N. Povydysh verfasserin aut PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials. лекарственное растительное сырьё метаболический синдром индивидуальные вещества растительного происхожения Pharmaceutical industry V. G. Luzhanin verfasserin aut D. Yu. Ivkin verfasserin aut M. V. Belousov verfasserin aut G. P. Yakovlev verfasserin aut In Разработка и регистрация лекарственных средств LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 (2019), 3, Seite 130-135 (DE-627)1760622966 26585049 nnns year:2019 number:3 pages:130-135 https://doaj.org/article/d62765a783af439a9d7dffcf6b4d59b9 kostenfrei https://www.pharmjournal.ru/jour/article/view/615 kostenfrei https://doaj.org/toc/2305-2066 Journal toc kostenfrei https://doaj.org/toc/2658-5049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2019 3 130-135 |
| allfieldsGer |
(DE-627)DOAJ029609100 (DE-599)DOAJd62765a783af439a9d7dffcf6b4d59b9 DE-627 ger DE-627 rakwb rus HD9665-9675 M. N. Povydysh verfasserin aut PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials. лекарственное растительное сырьё метаболический синдром индивидуальные вещества растительного происхожения Pharmaceutical industry V. G. Luzhanin verfasserin aut D. Yu. Ivkin verfasserin aut M. V. Belousov verfasserin aut G. P. Yakovlev verfasserin aut In Разработка и регистрация лекарственных средств LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 (2019), 3, Seite 130-135 (DE-627)1760622966 26585049 nnns year:2019 number:3 pages:130-135 https://doaj.org/article/d62765a783af439a9d7dffcf6b4d59b9 kostenfrei https://www.pharmjournal.ru/jour/article/view/615 kostenfrei https://doaj.org/toc/2305-2066 Journal toc kostenfrei https://doaj.org/toc/2658-5049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2019 3 130-135 |
| allfieldsSound |
(DE-627)DOAJ029609100 (DE-599)DOAJd62765a783af439a9d7dffcf6b4d59b9 DE-627 ger DE-627 rakwb rus HD9665-9675 M. N. Povydysh verfasserin aut PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials. лекарственное растительное сырьё метаболический синдром индивидуальные вещества растительного происхожения Pharmaceutical industry V. G. Luzhanin verfasserin aut D. Yu. Ivkin verfasserin aut M. V. Belousov verfasserin aut G. P. Yakovlev verfasserin aut In Разработка и регистрация лекарственных средств LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020 (2019), 3, Seite 130-135 (DE-627)1760622966 26585049 nnns year:2019 number:3 pages:130-135 https://doaj.org/article/d62765a783af439a9d7dffcf6b4d59b9 kostenfrei https://www.pharmjournal.ru/jour/article/view/615 kostenfrei https://doaj.org/toc/2305-2066 Journal toc kostenfrei https://doaj.org/toc/2658-5049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2019 3 130-135 |
| language |
Russian |
| source |
In Разработка и регистрация лекарственных средств (2019), 3, Seite 130-135 year:2019 number:3 pages:130-135 |
| sourceStr |
In Разработка и регистрация лекарственных средств (2019), 3, Seite 130-135 year:2019 number:3 pages:130-135 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
лекарственное растительное сырьё метаболический синдром индивидуальные вещества растительного происхожения Pharmaceutical industry |
| isfreeaccess_bool |
true |
| container_title |
Разработка и регистрация лекарственных средств |
| authorswithroles_txt_mv |
M. N. Povydysh @@aut@@ V. G. Luzhanin @@aut@@ D. Yu. Ivkin @@aut@@ M. V. Belousov @@aut@@ G. P. Yakovlev @@aut@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
1760622966 |
| id |
DOAJ029609100 |
| language_de |
russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ029609100</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410120327.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2019 xx |||||o 00| ||rus c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ029609100</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJd62765a783af439a9d7dffcf6b4d59b9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9665-9675</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">M. N. Povydysh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">лекарственное растительное сырьё</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">метаболический синдром</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">индивидуальные вещества растительного происхожения</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">V. G. Luzhanin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. Yu. Ivkin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. V. Belousov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">G. P. Yakovlev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Разработка и регистрация лекарственных средств</subfield><subfield code="d">LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020</subfield><subfield code="g">(2019), 3, Seite 130-135</subfield><subfield code="w">(DE-627)1760622966</subfield><subfield code="x">26585049</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2019</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:130-135</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/d62765a783af439a9d7dffcf6b4d59b9</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.pharmjournal.ru/jour/article/view/615</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2305-2066</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5049</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2019</subfield><subfield code="e">3</subfield><subfield code="h">130-135</subfield></datafield></record></collection>
|
| callnumber-first |
H - Social Science |
| author |
M. N. Povydysh |
| spellingShingle |
M. N. Povydysh misc HD9665-9675 misc лекарственное растительное сырьё misc метаболический синдром misc индивидуальные вещества растительного происхожения misc Pharmaceutical industry PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM |
| authorStr |
M. N. Povydysh |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760622966 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
HD9665-9675 |
| illustrated |
Not Illustrated |
| issn |
26585049 |
| topic_title |
HD9665-9675 PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM лекарственное растительное сырьё метаболический синдром индивидуальные вещества растительного происхожения |
| topic |
misc HD9665-9675 misc лекарственное растительное сырьё misc метаболический синдром misc индивидуальные вещества растительного происхожения misc Pharmaceutical industry |
| topic_unstemmed |
misc HD9665-9675 misc лекарственное растительное сырьё misc метаболический синдром misc индивидуальные вещества растительного происхожения misc Pharmaceutical industry |
| topic_browse |
misc HD9665-9675 misc лекарственное растительное сырьё misc метаболический синдром misc индивидуальные вещества растительного происхожения misc Pharmaceutical industry |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Разработка и регистрация лекарственных средств |
| hierarchy_parent_id |
1760622966 |
| hierarchy_top_title |
Разработка и регистрация лекарственных средств |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760622966 |
| title |
PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM |
| ctrlnum |
(DE-627)DOAJ029609100 (DE-599)DOAJd62765a783af439a9d7dffcf6b4d59b9 |
| title_full |
PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM |
| author_sort |
M. N. Povydysh |
| journal |
Разработка и регистрация лекарственных средств |
| journalStr |
Разработка и регистрация лекарственных средств |
| callnumber-first-code |
H |
| lang_code |
rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
txt |
| container_start_page |
130 |
| author_browse |
M. N. Povydysh V. G. Luzhanin D. Yu. Ivkin M. V. Belousov G. P. Yakovlev |
| class |
HD9665-9675 |
| format_se |
Elektronische Aufsätze |
| author-letter |
M. N. Povydysh |
| author2-role |
verfasserin |
| title_sort |
prospects of using phytotherapy at disorders of fat and carbohydrate metabolism |
| callnumber |
HD9665-9675 |
| title_auth |
PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM |
| abstract |
The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials. |
| abstractGer |
The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials. |
| abstract_unstemmed |
The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
3 |
| title_short |
PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM |
| url |
https://doaj.org/article/d62765a783af439a9d7dffcf6b4d59b9 https://www.pharmjournal.ru/jour/article/view/615 https://doaj.org/toc/2305-2066 https://doaj.org/toc/2658-5049 |
| remote_bool |
true |
| author2 |
V. G. Luzhanin D. Yu. Ivkin M. V. Belousov G. P. Yakovlev |
| author2Str |
V. G. Luzhanin D. Yu. Ivkin M. V. Belousov G. P. Yakovlev |
| ppnlink |
1760622966 |
| callnumber-subject |
HD - Industries, Land Use, Labor |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| callnumber-a |
HD9665-9675 |
| up_date |
2024-07-03T23:39:03.182Z |
| _version_ |
1803603089223057408 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ029609100</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410120327.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2019 xx |||||o 00| ||rus c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ029609100</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJd62765a783af439a9d7dffcf6b4d59b9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9665-9675</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">M. N. Povydysh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">лекарственное растительное сырьё</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">метаболический синдром</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">индивидуальные вещества растительного происхожения</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">V. G. Luzhanin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. Yu. Ivkin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. V. Belousov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">G. P. Yakovlev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Разработка и регистрация лекарственных средств</subfield><subfield code="d">LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020</subfield><subfield code="g">(2019), 3, Seite 130-135</subfield><subfield code="w">(DE-627)1760622966</subfield><subfield code="x">26585049</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2019</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:130-135</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/d62765a783af439a9d7dffcf6b4d59b9</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.pharmjournal.ru/jour/article/view/615</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2305-2066</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5049</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2019</subfield><subfield code="e">3</subfield><subfield code="h">130-135</subfield></datafield></record></collection>
|
| score |
7.402669 |